Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Daewoong's "Leaps and Bounds" Q3 Performance, Exceeds KRW 20B in Operating Income for Three Consecutive Quarters 2021-11-02 21:00
GenScript Expands Commercial Production in U.S. with State-of-the-Art Gene Synthesis Center 2021-11-02 19:30
New discovery: Banana beats insomnia and anti-anxiety, approved by the US FDA 2021-11-02 09:00
Invetech Named Victorian Top Exporter of the Year 2021-10-30 05:35
Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia 2021-10-29 19:15
Operating Income of Yiling Pharmaceutical in First 3 Quarters Reaches CNY 8.112 Billion, Up 25.81% 2021-10-29 17:17
Appendix 4C - Q1 FY22 Quarterly Cash Flow Report 2021-10-29 14:50
Aiming for Global CDMO, Xcell Therapeutics opens an export route to 62 countries with cell therapy culture technology. 2021-10-28 21:00
HanAll Biopharma Reports Third Quarter 2021 Results 2021-10-28 21:00
WuXi Biologics Completes GMP Inspection by Health Canada for Drug Substance Facility 2021-10-28 08:30
Frontier Biotechnologies' Long-acting Injectable (Aikening(R)), in a Two Drug Regimen, Proves Safe and Effective for Critically Ill Hospitalized AIDS Patients 2021-10-27 20:47
I-Mab Announces Strategic Partnership with Sinopharm in Preparation for Launch of its Innovative Assets in China 2021-10-26 20:00
Samsung Biologics Reports Third Quarter 2021 Financial Results 2021-10-26 15:23
Angel Pharmaceuticals Announces Approval of IND Application in China for ITK Inhibitor CPI-818 2021-10-26 07:30
SCN9A Antisense Pain Killer OLP-1002 Moves into Phase 2a Stage 2021-10-25 20:30
Happiness Biotech Acquires Majority Ownership in Fujian Shennong 2021-10-25 20:00
Meet the Next Resolution in Medicine -- Polaris Biology Releases Starion™, the next-generation mass cytometer 2021-10-23 15:05
2021 Bio-enzyme Application Explorer Summit held in Chengdu 2021-10-22 14:23
Specialised Therapeutics Enters into a New Supply and Distribution Agreement with Incyte to Launch Two New Cancer Therapies, Tafasitamab and Pemigatinib, in Australia, New Zealand and Singapore 2021-10-22 09:00
Luoxin Pharmaceutical signs licensing agreement with Austria-based Marinomed Biotech AG for Budesolv® Budesonide Nasal Spray 2021-10-21 15:58
1 136 137 138 139 140 261